Hans Jörg Reinhardt
Voorzitter bij NOVARTIS AG
Vermogen: 75 M $ op 31-10-2024
Profiel
Hans Jrg Reinhardt is een Duitse zakenman die aan het roer heeft gestaan van 9 verschillende ondernemingen. Momenteel is hij onafhankelijk niet-uitvoerend voorzitter van Novartis AG, voorzitter van Novartis, Inc., voorzitter van de raad van commissarissen van Novartis International AG, voorzitter van Novartis Institutes for Biomedical Research, Inc. en voorzitter van de raad van commissarissen van Novartis Pharma AG (allemaal dochterondernemingen van Novartis AG) en voorzitter van het Institute of Molecular & Clinical Ophthalmology Basel. Hans Jrg Reinhardt is ook lid van de raad van bestuur van Swiss Re AG en voorzitter van de Novartis Foundation en lid van de raad van bestuur van de International Federation of Pharmaceutical Manufacturers. In zijn vorige loopbaan was Dr. Reinhardt voorzitter van het Genomics Institute van de Novartis Research Foundation, Chief Operating Officer bij Novartis AG en Head-Development bij Sandoz Pharmaceuticals AG (een dochteronderneming van Novartis AG) en Chairman-Management Board bij Bayer HealthCare AG. Hans Jrg Reinhardt promoveerde aan de Universitt des Saarlandes.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
NOVARTIS AG
0.03% | 31-12-2023 | 655 336 ( 0.03% ) | 71 M $ | 31-10-2024 |
SWISS RE AG
0.01% | 31-12-2023 | 31 831 ( 0.01% ) | 4 M $ | 31-10-2024 |
Actieve functies van Hans Jörg Reinhardt
Bedrijven | Functie | Begin |
---|---|---|
NOVARTIS AG | Voorzitter | 01-01-2013 |
SWISS RE LTD | Directeur/Bestuurslid | 21-04-2017 |
Novartis Finance Corp | Voorzitter | - |
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV Miscellaneous Commercial ServicesCommercial Services Helmholtz-Gemeinschaft Deutscher Forschungszentren eV operates as a scientific research organization. It performs cutting-edge research which contributes substantially to solving the grand challenges of science, society, and industry. The firm focuses on six research fields: Energy, Earth and Environment, Health, Key Technologies, Structure of Matter plus Aeronautics, Space, and Transport. It develops research programs for each of these fields. The company was founded in 1995 and is headquartered in Berlin, Germany. | Corporate Officer/Principal | - |
Novartis Pharma BV
Novartis Pharma BV Part of Novartis AG, Novartis Pharma BV is a Dutch healthcare company that provides solutions to address the evolving needs of patients worldwide. The company is based in Amsterdam, the Netherlands. Novartis is one of the largest pharmaceutical companies in the world. The company explores and develop innovative treatment methods to reach as many people as possible. The company was founded in 1996. The CEO is Vasant Narasimhan. | Voorzitter | - |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Voorzitter | - |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Voorzitter | 01-01-2013 |
Institut für molekulare und klinische Ophthalmologie Basel | Voorzitter | - |
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | Voorzitter | 01-01-2013 |
░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░ | - |
Eerdere bekende functies van Hans Jörg Reinhardt
Bedrijven | Functie | Einde |
---|---|---|
░░░░░ ░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░ | ░░░░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░░░░░░ ░░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Opleiding van Hans Jörg Reinhardt
Universität des Saarlandes | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
NOVARTIS AG | Health Technology |
LONZA GROUP AG | Health Technology |
SWISS RE LTD | Finance |
Bedrijven in privébezit | 16 |
---|---|
MorphoSys AG
MorphoSys AG BiotechnologyHealth Technology MorphoSys AG is a biopharmaceutical company, which engages in the development and commercialization of cancer therapeutics. Its clinical programs focus on Pelabresib and Tulmimetostat. The company was founded by Andreas Pluckthun and Simon E. Moroney in July 1992 and is headquartered in Planegg, Germany. | Health Technology |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Health Technology |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
Novartis Institute for Functional Genomics, Inc.
Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institute For Functional Genomics, Inc. serves as a bridge between basic science and preclinical drug discovery for Novartis’ global research organization. Its focus areas include oncology, autoimmunity, cardiovascular disease, diabetes, musculoskeletal disorders, and infectious disease. The company was founded in 1999 and is headquartered in San Diego, CA. | Commercial Services |
Novartis Foundation | |
Bayer HealthCare AG
Bayer HealthCare AG Pharmaceuticals: MajorHealth Technology Bayer HealthCare AG provides healthcare, agriculture, plastics and chemical products. It is an independent company comprising five divisions: Animal Health, Consumer Care, Diabetes Care, Diagnostics and Pharmaceuticals. The company covers the fields of animal health, genetically produced medicines, over the counter products, diagnostic products and prescription drugs. The company is headquartered in Leverkusen, Germany. | Health Technology |
Sandoz Pharmaceuticals AG
Sandoz Pharmaceuticals AG BiotechnologyHealth Technology Sandoz Pharmaceuticals AG develops and produces biopharmaceuticals. The firm specializes in the production of biopharmaceutical and biosimilars for the treatment and prevention of chronic diseases. It focuses on finding cure for diseases, such as cancer, multiple sclerosis, rheumatoid arthritis, and inherited metabolic disorders. The company was founded on January 6, 2006 and is headquartered in Rotkreuz, Switzerland. | Health Technology |
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | Health Technology |
Institut für molekulare und klinische Ophthalmologie Basel | |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
Novartis Pharma BV
Novartis Pharma BV Part of Novartis AG, Novartis Pharma BV is a Dutch healthcare company that provides solutions to address the evolving needs of patients worldwide. The company is based in Amsterdam, the Netherlands. Novartis is one of the largest pharmaceutical companies in the world. The company explores and develop innovative treatment methods to reach as many people as possible. The company was founded in 1996. The CEO is Vasant Narasimhan. | |
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV Miscellaneous Commercial ServicesCommercial Services Helmholtz-Gemeinschaft Deutscher Forschungszentren eV operates as a scientific research organization. It performs cutting-edge research which contributes substantially to solving the grand challenges of science, society, and industry. The firm focuses on six research fields: Energy, Earth and Environment, Health, Key Technologies, Structure of Matter plus Aeronautics, Space, and Transport. It develops research programs for each of these fields. The company was founded in 1995 and is headquartered in Berlin, Germany. | Commercial Services |
Novartis Finance Corp | Finance |
Abadia Retuerta SA
Abadia Retuerta SA Beverages: AlcoholicConsumer Non-Durables Part of Novartis AG, Abadia Retuerta SA offers outdoor experiences that immerse you in the nature of Abadia Retuerta. The company is based in Sardon de Duero, Spain. Activities include a campero aperitif, horseback riding, hot air balloon rides, falconry, and more. Enjoy a unique experience with exquisite food and wine tastings. | Consumer Non-Durables |